{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:39:05Z","timestamp":1792172345994,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clineuro.2021.106823","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T11:13:45Z","timestamp":1626520425000},"page":"106823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Therapeutic plasma exchange in clinical pediatric neurology practice: Experience from a tertiary referral hospital"],"prefix":"10.1016","volume":"207","author":[{"given":"Mira\u00e7","family":"Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Bekta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edin","family":"Botan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anar","family":"Gurbanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Teber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan\u0131l","family":"Kendirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2021.106823_bib1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archneur.63.7.930","article-title":"Plasma exchange in neuroimmunological disorders: Part 1: rationale and treatment of inflammatory central nervous system disorders","volume":"63","author":"Lehmann","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.12629","article-title":"The mechanisms of action of plasma exchange","volume":"164","author":"Reeves","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clineuro.2021.106823_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jca.21242","article-title":"Pediatric therapeutic plasma exchange indications and patterns of use in US children\u2019s hospitals","volume":"27","author":"Weiss","year":"2012","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.clineuro.2021.106823_bib4","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.clineuro.2021.106823_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13760-018-0961-5","article-title":"Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience","volume":"118","author":"\u00d6zkale","year":"2018","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.clineuro.2021.106823_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/0883073814545883","article-title":"Outcomes after early administration of plasma exchange in pediatric central nervous system inflammatory demyelination","volume":"30","author":"Bigi","year":"2015","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.msard.2019.07.004","article-title":"A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children","volume":"35","author":"Manguinao","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clineuro.2021.106823_bib8","series-title":"Neuromuscular Disorders in Clinical Practice","first-page":"592","article-title":"Guillain-Barr\u00e9 syndrome and related disorders","author":"Piccione","year":"2014"},{"key":"10.1016\/j.clineuro.2021.106823_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ana.22427","article-title":"Acute ischemic stroke in children versus young adults","volume":"70","author":"Bigi","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1212\/CPJ.0000000000000480","article-title":"Safety and efficacy of plasma exchange in pediatric transverse myelitis","volume":"8","author":"Noland","year":"2018","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.clineuro.2021.106823_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0972-2327.144301","article-title":"Plasmapheresis in neurological disorders: experience from a tertiary care hospital in South India","volume":"18","author":"Gafoor","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clineuro.2017.05.006","article-title":"Guillain-Barr\u00e9 syndrome, variants & forms fruste: reclassification with new criteria","volume":"158","author":"Hiew","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clineuro.2021.106823_bib13","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.clineuro.2021.106823_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mus.26831","article-title":"Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain-Barr\u00e9 syndrome","volume":"61","author":"Beydoun","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2021.106823_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Quality standards subcommittee of the American Academy of Neurology. Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2021.106823_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000007719","article-title":"Current treatment practice of Guillain-Barr\u00e9 syndrome","volume":"93","author":"Verboon","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2021.106823_bib17","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/cc10305","article-title":"Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 syndrome: a randomized study","volume":"15","author":"El-Bayoumi","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.clineuro.2021.106823_bib18","article-title":"Treatment for Fisher syndrome, Bickerstaff\u2019s brainstem encephalitis and related disorders","volume":"1","author":"Overell","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.clineuro.2021.106823_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pediatrneurol.2013.10.016","article-title":"Recurrent Miller Fisher syndrome in children","volume":"50","author":"Grosso","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1528-1167.2011.03350.x","article-title":"Long-term follow-up of febrile infection-related epilepsy syndrome","volume":"53","author":"Howell","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2021.106823_bib21","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1528-1167.2011.03250.x","article-title":"Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children","volume":"52","author":"Kramer","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2021.106823_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0404.2009.01198.x","article-title":"Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis","volume":"121","author":"Sakuma","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2021.106823_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.seizure.2013.04.005","article-title":"Febrile infection-related epilepsy syndrome: a study of 12 patients","volume":"22","author":"Caraballo","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.clineuro.2021.106823_bib24","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1212\/NXI.0000000000000207","article-title":"Immunoadsorption therapy in autoimmune encephalitides","volume":"3","author":"Dogan Onugoren","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2021.106823_bib25","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00415-016-8277-y","article-title":"Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study","volume":"263","author":"Heine","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.braindev.2016.01.009","article-title":"Plasma exchange in pediatric anti-NMDAR encephalitis: a systematic review","volume":"38","author":"Suppiej","year":"2016","journal-title":"Brain Dev."},{"key":"10.1016\/j.clineuro.2021.106823_bib27","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune therapy in autoimmune encephalitis: a systematic review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.clineuro.2021.106823_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/ane.12618","article-title":"Hashimoto encephalopathy: literature review","volume":"135","author":"Zhou","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2021.106823_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jfma.2011.05.012","article-title":"Hashimoto\u2019s encephalopathy: report of three cases","volume":"113","author":"Chang","year":"2014","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.clineuro.2021.106823_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jca.21597","article-title":"Therapeutic plasma exchange for Hashimoto\u2019s encephalopathy","volume":"33","author":"Simmons","year":"2018","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.clineuro.2021.106823_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/1744-9987.13466","article-title":"Successful treatment of Hashimoto encephalopathy with therapeutic plasma exchange","volume":"24","author":"Attique","year":"2020","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.clineuro.2021.106823_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.clineuro.2021.106823_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jca.21342","article-title":"Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response","volume":"30","author":"Farooqi","year":"2015","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.clineuro.2021.106823_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2021.106823_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2021.106823_bib36","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/01.wnl.0000260970.63493.c8","article-title":"Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide","volume":"68","author":"Greenberg","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2021.106823_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2016.11.010","article-title":"Plasmapheresis for refractory status epilepticus. Part II: a scoping systematic review of the pediatric literature","volume":"43","author":"Zeiler","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.clineuro.2021.106823_bib38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0272-6386(12)80135-1","article-title":"Therapeutic plasma exchange: complications and management","volume":"23","author":"Mokrzycki","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clineuro.2021.106823_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0883073817749368","article-title":"Therapeutic plasma exchange use in pediatric neurologic disorders at a tertiary care center: a 10-year review","volume":"33","author":"Agarwal","year":"2018","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib40","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/j.1537-2995.2007.01405.x","article-title":"Complications of apheresis in children","volume":"47","author":"Michon","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.clineuro.2021.106823_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpn.2020.04.001","article-title":"Feasibility & safety of plasma exchange in paediatric neuro-immunology: a single center experience","volume":"27","author":"Shah","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.clineuro.2021.106823_bib42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/dmcn.14150","article-title":"Utility and safety of plasma exchange in paediatric neuroimmune disorders","volume":"61","author":"Eyre","year":"2019","journal-title":"Dev. Med. Child. Neurol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721003528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721003528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:42:35Z","timestamp":1759588955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721003528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S0303846721003528"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106823","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic plasma exchange in clinical pediatric neurology practice: Experience from a tertiary referral hospital","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106823"}}